Position in SPRY
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$2,294,395
-$3,321,882 QoQ
Shares Held
285,728
-40.7% QoQ
Ownership
0.288%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Derivatives in SPRY
reported options exposure · as of Sep 30, 2024CallValue
$971,500
CallShares
67,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. SPRY ranks #170 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in SPRY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,294,395 | 285,728 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $5,616,277 | 482,084 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,733,860 | 272,026 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $5,677,391 | 325,352 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,594,362 | 444,703 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,698,104 | 160,958 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $971,500 | 67,000 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $1,636,528 | 112,864 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $919,709 | 108,074 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $833,736 | 81,579 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $540,316 | 98,598 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $213,358 | 56,444 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $177,053 | 26,426 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $159,494 | 24,500 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $112,927 | 13,239 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $55,196 | 10,454 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,032,189 | 243,441 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $926,169 | 263,866 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $158,347 | 23,776 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $32,794 | 3,286 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,026,103 | 33,218 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,167,494 | 26,759 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||